Advertisement

Advertisement

TOVX Stock Latest News

Theriva Biologics launches VIRAGE2 metastatic pancreatic trial

Company AnnouncementsTheriva Biologics launches VIRAGE2 metastatic pancreatic trial

Theriva Biologics gets regulatory authorization to proceed with VIRAGE2 in Spain

PremiumThe Fly

Theriva Biologics gets regulatory authorization to proceed with VIRAGE2 in Spain

1h ago

Theriva Biologics highlights promising VCN-01 Phase 1 results

PremiumCompany Announcements

Theriva Biologics highlights promising VCN-01 Phase 1 results

26d ago

Theriva Biologics Faces Quorum Issue Delaying Warrant Vote

PremiumCompany Announcements

Theriva Biologics Faces Quorum Issue Delaying Warrant Vote

1M ago

3 Penny Stocks to Watch Now, 4/21/26

PremiumMarket News

3 Penny Stocks to Watch Now, 4/21/26

3M ago

Theriva Biologics Highlights Positive VCN-01 Pancreatic Cancer Data

PremiumCompany AnnouncementsTheriva Biologics Highlights Positive VCN-01 Pancreatic Cancer Data

3M ago

Theriva Biologics to present additional data on Phase 2b VCN-01Clinical Trial

The Fly

Theriva Biologics to present additional data on Phase 2b VCN-01Clinical Trial

3M ago

Theriva Biologics Faces Delays in Warrant Approval Meeting

Company Announcements

Theriva Biologics Faces Delays in Warrant Approval Meeting

3M ago

Theriva Biologics upgraded to Buy at Maxim on clearer VCN-01 path

PremiumThe Fly

Theriva Biologics upgraded to Buy at Maxim on clearer VCN-01 path

3M ago

Theriva Biologics upgraded to Buy from Hold at Maxim

PremiumThe Fly

Theriva Biologics upgraded to Buy from Hold at Maxim

3M ago

Theriva Biologics Advances VCN-01 Into Pivotal Phase 3

PremiumCompany Announcements

Theriva Biologics Advances VCN-01 Into Pivotal Phase 3

4M ago

Theriva Biologics announces outcome of Type B End-of-Phase 2 meeting with FDA

PremiumThe Fly

Theriva Biologics announces outcome of Type B End-of-Phase 2 meeting with FDA

4M ago

Theriva Biologics price target lowered to $4 from $7 at Alliance Global

PremiumThe FlyTheriva Biologics price target lowered to $4 from $7 at Alliance Global

4M ago

Theriva Biologics reports FY25 EPS ($2.08) vs. ($19.03) last year

The Fly

Theriva Biologics reports FY25 EPS ($2.08) vs. ($19.03) last year

4M ago

Theriva Biologics sees cash runway into 1Q27

The Fly

Theriva Biologics sees cash runway into 1Q27

4M ago

Theriva Licenses SYN-020, Refocuses on Cancer Pipeline

PremiumCompany Announcements

Theriva Licenses SYN-020, Refocuses on Cancer Pipeline

5M ago

Theriva Biologics licenses SYN-020 to Rasayana Therapeutics

PremiumThe Fly

Theriva Biologics licenses SYN-020 to Rasayana Therapeutics

5M ago

Theriva Biologics Faces Delay in Warrant Approval Meeting

PremiumCompany Announcements

Theriva Biologics Faces Delay in Warrant Approval Meeting

5M ago

Theriva Biologics advances VCN-01 toward Phase 3 trial

PremiumCompany Announcements

Theriva Biologics advances VCN-01 toward Phase 3 trial

6M ago

Theriva Biologics Gains EMA Backing for VCN-01 Phase 3

PremiumCompany AnnouncementsTheriva Biologics Gains EMA Backing for VCN-01 Phase 3

6M ago

Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design

The Fly

Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design

6M ago

Theriva Biologics Reschedules Special Stockholder Meeting

Company Announcements

Theriva Biologics Reschedules Special Stockholder Meeting

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >